BioNTech SE (BNTX) Slides on Vaccine Revenue Miss But Consensus Was 'Too High'
August 8, 2022 3:32 PM
BioNTech SE (NASDAQ: BNTX) shares tumbled more than 9% Monday after reporting second-quarter earnings before the open.The drugmaker posted second-quarter ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
